Ardena announces Commercial Agency Agreement with Keyfronbio

Belgium-based contract development and manufacturing organization, Ardena (East Flanders, Belgium), has announced the signing of a Commercial Agency Agreement for South Korea with life science company Keyfronbio (Chungcheongbuk-do, South Korea). The biotechnological industry has been recognized as a key economic driver in South Korea and a future engine for growth for the country. Contract development and manufacturing organization Ardena provides pharmaceutical companies with services spanning the drug development landscape – including solid-state research, drug product development and manufacturing and dossier development – to help enable them to bring their molecules to market. Formed in 2011, Keyfronbio is a subsidiary of...

To view this content, please register now for access

It's completely free